SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

NIGHT is drawing attention as traders react to a rebound alongside discussion of Midnights mainnet launch and ecosystem developments, including Google Clouds validator role and a reported Coinbase listing. Some see these as signs of growing adoption, while others remain cautious about weak follow-through and selling pressure from token unlocks and airdrops.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs agreement to acquire low-band spectrum and its plans to expand Starlink Mobile have driven concern that it could become a future competitor to T-Mobile and other wireless carriers. Traders debate whether that threat warrants the sharp selloff or is being overstated given the time and infrastructure needed to build a competing network, with many viewing the drop as a buying opportunity.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly shares are drawing attention for continued weakness and underperformance amid a broader pullback in space stocks, with traders debating whether SpaceX is pulling capital away from smaller companies and compressing sector valuations. Some see the decline as excessive given Fireflys contracts and long-term lunar ambitions, while others are frustrated by the stocks inability to hold gains.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Oppenheimers upgrade to Outperform, citing rising contract values and early monetization of agentic AI traffic, is driving attention to Fastly. Traders are broadly reacting bullishly to the growth thesis and rally, while some question how much AI traffic will translate into revenue and warn that the stocks sharp swings may fade.

GEOM maps the world's oil fields, mines, rare earths, and power plants, tracks what is and isn't tokenized, and cryptographically signs every dataset it publishes. Anyone can verify what we said and when. No account, no key, no permission. Sources include the WRI Global Power Plant Database and Global Energy Monitor (CC BY 4.0), attributed in full inside the app. Most of it already exists, spread across filings and terminals no one reads. GEOM gathers it and records where each figure came from.

GEOM

GEOM is drawing attention around its proposed platform for tokenizing oil and mineral assets and royalties, with traders linking its prospects to Greenland Energy (GLND) and anticipating platform or partner developments. Bullish holders see an early real-world-asset opportunity, while skeptics cite the tokens decline, thin liquidity, and uncertainty about execution.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

A recent pullback has prompted debate, with frustrated traders questioning the weakness while long-term holders point to Rolls-Royces aviation and defense growth prospects, including its India engine ambitions and A350F activity. Speculation about a hyperscaler or SMR-related deal also recurs, but traders acknowledge that a major hyperscaler announcement has not been confirmed.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transoceans new offshore contract and the addition of the Equinor agreement to firm backlog are drawing attention, alongside progress toward its Valaris merger. Traders see growing backlog and high oil prices as bullish, but many are frustrated that RIG has struggled to respond; claims that heavy shorting is suppressing the stock remain speculation.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds recent pullback and choppy rebound dominate discussion, with traders linking pressure on the metal to a stronger dollar, elevated Treasury yields, and hawkish Fed expectations. Some see a potential bottom and point to safe-haven and central-bank demand, while others warn the decline may continue.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgans upcoming third-quarter earnings report is a main focus, with traders also debating a pullback in bank stocks amid rising Treasury yields and concerns about loan growth, deposit costs and credit. Some see the weakness as an opportunity ahead of results, while others remain cautious about pressure on the sector.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A strong, high-volume rally is being attributed by traders to anticipation of founder Patrick Soon-Shiongs Piper Sandler fireside chat and potential trial updates; speculation about a partnership is circulating but remains unconfirmed. The community is also debating whether high short interest could amplify the move, while pointing to ANKTIVA and possible bladder-cancer label expansion as longer-term catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equillium, Inc. (NASDAQ:EQ) Receives Average Rating of "Moderate Buy" from Analysts

Equillium, Inc. (NASDAQ:EQ - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating, five have iss...

Roth Mkm Reiterates Buy Rating for Equillium (NASDAQ:EQ)

Roth Mkm restated a "buy" rating and set a $12.00 target price on shares of Equillium in a research report on Friday...

Equillium (NASDAQ:EQ) Earns Buy Rating from Analysts at B. Riley Financial

B. Riley Financial began coverage on Equillium in a research note on Thursday. They issued a "buy" rating and a $6.00 price target for the company...

Short Interest in Equillium, Inc. (NASDAQ:EQ) Grows By 36.6%

Equillium, Inc. (NASDAQ:EQ - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,727,834 shares, an...

Aberdeen Group plc Grows Stake in Equillium, Inc. $EQ

Aberdeen Group plc grew its holdings in Equillium, Inc. (NASDAQ:EQ - Free Report) by 523.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned...

Equillium, Inc. (NASDAQ:EQ) Given Average Rating of "Hold" by Brokerages

Equillium, Inc. (NASDAQ:EQ - Get Free Report) has received a consensus recommendation of "Hold" from the five analysts that are covering the company, Marketbeat reports. One analyst has rated the...

Cantor Fitzgerald Begins Coverage on Equillium (NASDAQ:EQ)

Cantor Fitzgerald initiated coverage on Equillium in a report on Tuesday. They set an "overweight" rating and a $10.00 price objective on the stock...

Equillium (NASDAQ:EQ) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Equillium (NASDAQ:EQ - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.04) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by...

Equillium (EQ) Expected to Announce Earnings on Thursday

Equillium (NASDAQ:EQ) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-equillium-inc-stock...

Equillium (NASDAQ:EQ) COO Sells $300,780.00 in Stock

Equillium, Inc. (NASDAQ:EQ - Get Free Report) COO Christine Zedelmayer sold 120,312 shares of the company's stock in a transaction that occurred on Friday, March 13th. The stock was sold at an...

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.

Equillium Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$EQ indicated it received Australian ethics and TGA clearance for its Phase 1 EQ504 trial, with dosing slated for early Nov 2026.

jorge .miguel

$EQ Results 
EQ504 induced robust, dose-dependent AhR activation, and was ∼10-fold more potent than the clinically validated AhR agonist obefazimod in the EROD assay. Functionally, EQ504 significantly accelerated epithelial wound closure in scratch assays, whereas obefazimod showed minimal or no effect under equivalent conditions. At matched concentrations, EQ504 increased expression of the IL-22 receptor subunit IL22RA and reduced expression of the pore-forming tight junction protein claudin-2 (CLDN2), consistent with enhanced epithelial repair, which were not observed with obefazimod.

Publius Valerius

$EQ they still haven't dosed anyone?? It was due in mid 26 and data in Q1 27? Wtf happened here 🤣🤣

Feed

News

Sentiment

Earnings

Fundamentals

Info

EQ Equillium Inc

Fundamentals

Latest EQ News